A business in context

DSGN research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-329579

  2. 8-K · Current report

    Report date 2026-08-03 · 0001193125-26-329570 · Items 2.02,9.01

  3. 4 · Ownership change

    Report date 2026-06-09 · 0001754129-26-000006

  4. 4 · Ownership change

    Report date 2026-06-09 · 0001751873-26-000002

  5. 4 · Ownership change

    Report date 2026-06-09 · 0001579826-26-000002

  6. 4 · Ownership change

    Report date 2026-06-09 · 0001559570-26-000008

  7. 4 · Ownership change

    Report date 2026-06-09 · 0001478916-26-000009

  8. 4 · Ownership change

    Report date 2026-06-09 · 0001193125-26-267732

  9. 8-K · Current report

    Report date 2026-06-09 · 0001193125-26-267485 · Items 5.07

  10. 8-K · Current report

    Report date 2026-05-18 · 0001193125-26-227875 · Items 8.01

  11. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-187063

  12. 8-K · Current report

    Report date 2026-04-28 · 0001193125-26-187012 · Items 2.02,7.01

  13. DEF 14A · Proxy statement

    Report date 2026-04-23 · 0001193125-26-173678

  14. 4 · Ownership change

    Report date 2026-03-31 · 0001559570-26-000006

  15. 8-K · Current report

    Report date 2026-03-31 · 0001193125-26-137861 · Items 5.02

  16. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-098491

  17. 8-K · Current report

    Report date 2026-03-09 · 0001193125-26-098474 · Items 2.02,9.01

  18. 8-K · Current report

    Report date 2026-01-29 · 0001193125-26-031772 · Items 5.02

  19. 4 · Ownership change

    Report date 2026-01-02 · 0001883722-26-000002

  20. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-266970

  21. 8-K · Current report

    Report date 2025-11-05 · 0001193125-25-266933 · Items 2.02,9.01

  22. 8-K · Current report

    Report date 2025-09-09 · 0001807120-25-000004 · Items 5.02

  23. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-105062

  24. 8-K · Current report

    Report date 2025-08-07 · 0000950170-25-105008 · Items 2.02,7.01

  25. 8-K · Current report

    Report date 2025-06-10 · 0000950170-25-085380 · Items 5.07

  26. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-065643

  27. 8-K · Current report

    Report date 2025-05-07 · 0000950170-25-065613 · Items 2.02,9.01

  28. DEF 14A · Proxy statement

    Report date 2025-06-10 · 0000950170-25-058008

  29. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-035910

  30. 8-K · Current report

    Report date 2025-03-10 · 0000950170-25-035909 · Items 2.02,9.01

  31. 8-K · Current report

    Report date 2025-01-13 · 0000950170-25-004612 · Items 7.01,9.01

  32. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-123349

  33. 8-K · Current report

    Report date 2024-11-07 · 0000950170-24-123289 · Items 2.02,9.01

  34. SC 13D/A · Ownership disclosure

    0000935836-24-000514

  35. 10-Q · Quarterly report

    Report date 2024-06-30 · 0000950170-24-090337

  36. 8-K · Current report

    Report date 2024-08-05 · 0000950170-24-090332 · Items 2.02,9.01

  37. 8-K · Current report

    Report date 2024-06-13 · 0000950170-24-074243 · Items 5.07

  38. 10-Q · Quarterly report

    Report date 2024-03-31 · 0000950170-24-055788

  39. 8-K · Current report

    Report date 2024-05-08 · 0000950170-24-055645 · Items 2.02,9.01

  40. DEF 14A · Proxy statement

    Report date 2024-06-13 · 0000950170-24-048385

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001807120Design Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$0$0

    Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

    Explore the CPI history ↗